written on 22.04.2014
Tags:
,

Pfizer to plunk down $190M to wrap up Neurontin class action

TAGS: ,

In the latest settlement of a Big Pharma-delays-generics case, Pfizer has agreed to pay $190 million to wrap up a class-action suit over its seizure drug Neurontin. More than a decade old, the lawsuit claimed that Pfizer did some fast tap-dancing to prolong its Neurontin monopoly.

Latest Report